B Group, Inc.

Insider Reports History

Location
Dallas, TX
Signature
/s/ Branden B. Muhl, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by B Group, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. 10%+ Owner Common Stock 3,000,000 $8,820,000 $2.94 18 Aug 2025 Indirect

Insider Reports Filed by B Group, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRXP NRX Pharmaceuticals, Inc. 18 Aug 2025 0 $0 3 10%+ Owner 21 Aug 2025, 06:21